Cargando…

Radiotherapy improves survival in early stage extranodal natural killer/T cell lymphoma patients receiving asparaginase-based chemotherapy

This study retrospectively investigated asparaginase-based chemotherapy treatment outcomes with or without radiotherapy in 143 patients with stage I(E)–II(E) extranodal natural killer/T cell lymphoma (ENKTCL). All patients received a median of three cycles of asparaginase-based chemotherapy, while 1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yi-Yang, Feng, Ling-Ling, Niu, Shao-Qing, Wang, Han-Yu, Zhang, Lu-Lu, Wang, Liang, Xia, Zhong-Jun, Huang, Hui-Qiang, Xia, Yun-Fei, Zhang, Yu-Jing, Wang, Xi-Cheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355279/ https://www.ncbi.nlm.nih.gov/pubmed/28002792 http://dx.doi.org/10.18632/oncotarget.14006

Ejemplares similares

Increased serum levels of interleukin-10 predict poor prognosis in extranodal natural killer/T-cell lymphoma patients receiving asparaginase-based chemotherapy
por: Wang, Hua, et al.
Publicado: (2015)

Intensity-modulated radiotherapy has superior outcomes to three-dimensional conformal radiotherapy in patients with stage IE-IIE extranodal nasal-type natural killer/T-cell lymphoma
por: Li, Yi-Yang, et al.
Publicado: (2017)

Asparagine synthetase expression is associated with the sensitivity to asparaginase in extranodal natural killer/T-cell lymphoma in vivo and in vitro
por: Liu, Wen-jian, et al.
Publicado: (2018)

CD56-Negative Extranodal Natural Killer/T-Cell Lymphoma: A Retrospective Study in 443 Patients Treated by Chemotherapy With or Without Asparaginase
por: Yang, Jing, et al.
Publicado: (2022)

Lymphocyte/Monocyte Ratio is a Novel Predictor for Early Stage Extranodal Natural Killer/T-cell Lymphoma, Nasal Type
por: Wang, Qiao-xuan, et al.
Publicado: (2017)

Post-treatment plasma EBV-DNA positivity predicts early relapse and poor prognosis for patients with extranodal NK/T cell lymphoma in the era of asparaginase
por: Wang, Liang, et al.
Publicado: (2015)

Primary site and regional lymph node involvement are independent prognostic factors for early-stage extranodal nasal-type natural killer/T cell lymphoma
por: Niu, Shao-Qing, et al.
Publicado: (2016)

Chemotherapy combined with high-dose extended-field radiotherapy for stage I extranodal nasal-type natural killer/T-cell lymphoma
por: Luo, Jialin, et al.
Publicado: (2016)

Promising clinical outcomes of sequential and “Sandwich” chemotherapy and extended involved‐field intensity‐modulated radiotherapy in patients with stage I(E)/II(E) extranodal natural killer/T‐cell lymphoma
por: Wang, Han‐yu, et al.
Publicado: (2018)

Risk-Dependent Conditional Survival and Failure Hazard After Radiotherapy for Early-Stage Extranodal Natural Killer/T-Cell Lymphoma
por: Liu, Xin, et al.
Publicado: (2019)

Sequential P‐GEMOX and radiotherapy for early‐stage extranodal natural killer/T‐cell lymphoma: A multicenter study
por: Zhang, Yuchen, et al.
Publicado: (2021)

Phase II study of sequential chemoradiotherapy with L-asparaginase, dexamethasone, ifosfamide, cisplatin, and etoposide (DICE-L) in the early stage of extranodal natural killer (NK)/T-cell lymphoma
por: Zhang, Yao, et al.
Publicado: (2021)

Consolidative treatment after salvage chemotherapy improves prognosis in patients with relapsed extranodal natural killer/T-cell lymphoma
por: Nie, Man, et al.
Publicado: (2016)

L-asparaginase-induced severe acute pancreatitis in an adult with extranodal natural killer/T-cell lymphoma, nasal type: A case report and review of the literature
por: WU, FANG, et al.
Publicado: (2014)

Salvage radiotherapy improves survival in patients with locoregionally relapsed stage IE–IIE extranodal natural killer/T-cell lymphoma, nasal type
por: Tong, Qin, et al.
Publicado: (2018)

Utility of baseline, interim and end-of-treatment (18)F-FDG PET/CT in extranodal natural killer/T-cell lymphoma patients treated with L-asparaginase/pegaspargase
por: Chang, Yu, et al.
Publicado: (2017)

LncRNA BCYRN1-induced autophagy enhances asparaginase resistance in extranodal NK/T-cell lymphoma
por: Wang, Liang, et al.
Publicado: (2021)

The Roles of Radiotherapy and Chemotherapy in the Era of Multimodal Treatment for Early-Stage Nasal-Type Extranodal Natural Killer/T-Cell Lymphoma
por: Kim, Tae Hyung, et al.
Publicado: (2016)

Prognostic significance of peripheral monocyte count in patients with extranodal natural killer/T-cell lymphoma
por: Huang, Jia-Jia, et al.
Publicado: (2013)

Allogeneic Hematopoietic Stem Cell Transplantation in Extranodal Natural Killer/T-cell Lymphoma
por: Peng, Yin-yin, et al.
Publicado: (2021)

Histological vascular invasion is a novel prognostic indicator in extranodal natural killer/T-cell lymphoma, nasal type
por: Wang, Hua, et al.
Publicado: (2016)

Radiation dose reduction for patients with extranodal NK/T-cell lymphoma with complete response after initial induction chemotherapy
por: Wang, Liang, et al.
Publicado: (2016)

Comparison of the clinical efficacies of two L‐asparaginase‐based chemotherapy regimens for newly diagnosed nasal‐type extranodal NK/T‐cell lymphoma
por: Wu, Wanchun, et al.
Publicado: (2023)

Feasibility of low-dose radiotherapy for patients with stage I/II extranodal NK-/T-cell lymphoma, nasal type achieving complete response after l-asparaginase-containing chemotherapy
por: Kim, Jae Sik, et al.
Publicado: (2022)

Gemcitabine, dexamethasone, and cisplatin (GDP) chemotherapy with sandwiched radiotherapy in the treatment of newly diagnosed stage IE/IIE extranodal natural killer/T‐cell lymphoma, nasal type
por: Tian, Shu, et al.
Publicado: (2019)

Evidence of cure for extranodal nasal-type natural killer/T-cell lymphoma with current treatment: an analysis of the CLCG database
por: Liu, Xin, et al.
Publicado: (2023)

Outcome and risk prediction of early progression in patients with extranodal natural killer/T cell lymphoma from the CLCG study
por: Li, Jia-Ying, et al.
Publicado: (2023)

Inhibition of extranodal NK/T-cell lymphoma by Chiauranib through an AIF-dependent pathway and its synergy with L-asparaginase
por: Gao, Tianxiao, et al.
Publicado: (2023)

A phase II prospective study of the “Sandwich” protocol, L-asparaginase, cisplatin, dexamethasone and etoposide chemotherapy combined with concurrent radiation and cisplatin, in newly diagnosed, I/II stage, nasal type, extranodal natural killer/T-cell lymphoma
por: Jiang, Ming, et al.
Publicado: (2017)

Association of improved overall survival with decreased distant metastasis following asparaginase-based chemotherapy and radiotherapy for intermediate- and high-risk early-stage extranodal nasal-type NK/T-cell lymphoma: a CLCG study
por: Zheng, X., et al.
Publicado: (2021)

Sequential chemotherapy followed by radiotherapy versus concurrent chemoradiotherapy in patients with stage I/II extranodal natural killer/T-cell lymphoma, nasal type
por: Lee, Jieun, et al.
Publicado: (2013)

Pegaspargase Combined with Concurrent Radiotherapy for Early‐Stage Extranodal Natural Killer/T‐Cell Lymphoma, Nasal Type: A Two‐Center Phase II Study
por: Wang, Hua, et al.
Publicado: (2020)

Optimal Courses of Chemotherapy Combined with Radiotherapy for Low-Risk Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: A Propensity Score Matching Analysis
por: Li, Jin, et al.
Publicado: (2020)

Genomic and transcriptomic landscapes of Epstein-Barr virus in extranodal natural killer T-cell lymphoma
por: Peng, Rou-Jun, et al.
Publicado: (2018)

Primary extranodal natural killer/T-cell nasal-type lymphoma of spine: A case report
por: Wang, Jie, et al.
Publicado: (2019)

Extranodal natural killer/T cell lymphoma, nasal type in the middle cranial fossa: A case report
por: Wang, Han, et al.
Publicado: (2018)

CD30 expression in extranodal natural killer/T-cell lymphoma, nasal type among 622 cases of mature T-cell and natural killer-cell lymphoma at a single institution in South China
por: Feng, Yanfen, et al.
Publicado: (2017)

Characteristics and prognosis of distant metastasis after primary treatment for early‐stage extranodal nasal‐type natural killer/T‐cell lymphoma from the China Lymphoma Collaborative Group database
por: Zheng, Xuan, et al.
Publicado: (2022)

Extranodal Natural-Killer/T-Cell Lymphoma, Nasal Type
por: Gill, Harinder, et al.
Publicado: (2010)

Extranodal natural killer/T-cell lymphoma of the tenosynovium of the hand
por: Lim, Yoo Li, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_0ictn26hu579hht256cshh7o2s